Exchange: NYSE·Updated 07:30 PM EDT

TFX News

News
all
press releases
Bruker Gains 66.3% in a Year: What's Driving the Rally?
BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.
Zacks
Bruker Gains 66.3% in a Year: What's Driving the Rally?
BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.
Zacks
More News
Reasons to Add Globus Medical Stock to Your Portfolio Now
GMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a debt-free balance sheet support its appeal.
Zacks
Charles River Gains 75.8% in a Year: What's Driving the Rally?
CRL shares have surged 75.8% in a year as RMS trends improve, AI-enabled testing expands and cash flow supports buybacks and investment.
Zacks
TFX or SONVY: Which Is the Better Value Stock Right Now?
TFX vs. SONVY: Which Stock Is the Better Value Option?
Zacks
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.
Zacks
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects
BSX's MedSurg segment supports growth, with Endoscopy and Neuromodulation gains offsetting Urology challenges and portfolio gaps.
Zacks
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard Technology
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the publication of its latest peer-reviewed study in the American Journal of Infection Control demonstrating that Central Venous Catheters (CVCs) protected with Arrowg+ard Technology were...
Business Wire
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
Teleflex (TFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks
Futures Slide As Oil Jumps, Bond Selloff Resumes After Trump Spurns Iran Offer
Futures Slide As Oil Jumps, Bond Selloff Resumes After Trump Spurns Iran Offer US futures are lower with Tech underperforming, alongside a drop in treasuries, as fading hopes for an imminent?breakthrough?in the Iran war sent oil prices higher and reignited worries that inflation is...
Zero Hedge
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now
QGEN's test menu expansion and strategic partnerships support growth, but cautious spending and competition may weigh on near-term gains.
Zacks

Advertisement|Remove ads.